Self-assembled PEGylated albumin nanoparticles (SPAN) as a platform for cancer chemotherapy and imaging

References

• Carter DC, Ho JX. (1994). Structure of serum albumin. Adv Protein Chem 45:153–203.
   PubMedGoogle Scholar
• Cho YW, Lee J, Lee SC, et al. (2004). Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J Control Release 97:249–57.
   PubMed Web of Science ®Google Scholar
• Crosasso P, Ceruti M, Brusa P, et al. (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release 63:19–30.
   PubMed Web of Science ®Google Scholar
• Crown J, O'Leary M. (2000). The taxanes: an update. Lancet 355:1176–8.
   PubMed Web of Science ®Google Scholar
• Curry S, Mandelkow H, Brick P, et al. (1998). Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 5:827–35.
   PubMed Web of Science ®Google Scholar
• De M, Miranda OR, Rana S, et al. (2009). Size and geometry dependent protein-nanoparticle self-assembly. Chem Commun 16:2157–9.
   Web of Science ®Google Scholar
• Desai N, Trieu V, Yao Z, et al. (2006). Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res 12:1317–24.
   PubMed Web of Science ®Google Scholar
• Fraier D, Cenacchi V, Frigerio E. (1998). Determination of a new polymer-bound paclitaxel derivative (PNU 166945), free paclitaxel and 7-epipaclitaxel in dog plasma and urine by reversed-phase high-performance liquid chromatography with UV detection. J Chromatogr A 797:295–303.
   PubMed Web of Science ®Google Scholar
• Geny B, Mettauer B, Muan B, et al. (1993). Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. J Am Coll Cardiol 22:1193–8.
   PubMed Web of Science ®Google Scholar
• Grzelczak M, Vermant J, Furst EM, et al. (2010). Directed self-assembly of nanoparticles. ACS Nano 4:3591–605.
   PubMed Web of Science ®Google Scholar
• Ibrahim NK, Desai N, Legha S, et al. (2002). Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 8:1038–44.
   PubMed Web of Science ®Google Scholar
• Inada Y, Takahashi K, Yoshimoto T, et al. (1986). Application of polyethylene glycol-modified enzymes in biotechnological processes: organic solvent-soluble enzymes. Trends Biotechnol 4:190–4.
   Web of Science ®Google Scholar
• Ke XY, Ng VWL, Ono RJ, et al. (2014). Role of non-covalent and covalent interactions in cargo loading capacity and stability of polymeric micelles. J Control Release 193:9–26.
   PubMed Web of Science ®Google Scholar
• Kim S, Shi YZ, Kim JY, et al. (2010). Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction. Expert Opin Drug Deliv 7:49–62.
   PubMed Web of Science ®Google Scholar
• Kim SH, Tan JPK, Nederberg F, et al. (2010). Hydrogen bonding-enhanced micelle assemblies for drug delivery. Biomaterials 31:8063–71.
   PubMed Web of Science ®Google Scholar
• Koudelka S, Turanek J. (2012). Liposomal paclitaxel formulations. J Control Release 163:322–34.
   PubMed Web of Science ®Google Scholar
• Kratz F. (2008). Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release: Off J Control Release Soc 132:171–83.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee SC, Acharya G, et al. (2003). Hydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic property. Pharm Res 20:1022–30.
   PubMed Web of Science ®Google Scholar
• Lundberg BB. (1997). A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol). J Pharm Pharmacol 49:16–21.
   PubMed Web of Science ®Google Scholar
• Maeda H. (2012). Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release 164:138–44.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–92.
   PubMed Web of Science ®Google Scholar
• Neumann E, Frei E, Funk D, et al. (2010). Native albumin for targeted drug delivery. Expert Opin Drug Deliv 7:915–25.
   PubMed Web of Science ®Google Scholar
• Sackett DL, Wolff J. (1987). Nile red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces. Anal Biochem 167:228–34.
   PubMed Web of Science ®Google Scholar
• Sercombe L, Veerati T, Moheimani F, et al. (2015). Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286.
   Web of Science ®Google Scholar
• Shin DH, Tam YT, Kwon GS. (2016). Polymeric micelle nanocarriers in cancer research. Front Chem Sci Eng 10:348–59.
   Web of Science ®Google Scholar
• Sparreboom A, Scripture CD, Trieu V, et al. (2005). Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol). Clin Cancer Res 11:4136–43.
   PubMed Web of Science ®Google Scholar
• Taylor C, Ibrahim NK, Page R, et al. (2002). Preliminary evidence of antitumor activity of ABI-007, a cremophor-free nanoparticle paclitaxel, in patients previously exposed to taxanes. Breast Cancer Res Treat 76:S132.
   Web of Science ®Google Scholar
• Uster PS, Allen TM, Daniel BE, et al. (1996). Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett 386:243–6.
   PubMed Web of Science ®Google Scholar
• Weber C, Coester C, Kreuter J, et al. (2000). Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm 194:91–102.
   PubMed Web of Science ®Google Scholar
• Yamada R, Kostova MB, Anchoori RK, et al. (2010). Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery. Cancer Biol Ther 9:192–203.
   PubMed Web of Science ®Google Scholar
• Yang L, Cui F, Cun D, et al. (2007). Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. Int J Pharm 340:163–72.
   PubMed Web of Science ®Google Scholar
• Yang CA, Tan JPK, Cheng W, et al. (2010). Supramolecular nanostructures designed for high cargo loading capacity and kinetic stability. Nano Today 5:515–23.
   Web of Science ®Google Scholar
• Yokoyama M. (2014). Polymeric micelles as drug carriers: their lights and shadows. J Drug Target 22:576–83.
   PubMed Web of Science ®Google Scholar
• Zhang XC, Jackson JK, Burt HM. (1996). Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 132:195–206.
   Web of Science ®Google Scholar